ADMA Biologics

About:

ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.

Website: https://www.admabiologics.com/

Top Investors: Hercules Capital, Ares Management, Perceptive Advisors, Aisling Capital, Oxford Finance LLC

Description:

ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of the Company’s lead product candidate RI-002.